Prestige Consumer Healthcare Inc (PBH)
70.55
+0.41
(+0.58%)
USD |
NYSE |
Apr 26, 16:00
70.55
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Debt to Equity Ratio: 0.7493 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7493 |
| September 30, 2023 | 0.8223 |
| June 30, 2023 | 0.8895 |
| March 31, 2023 | 0.93 |
| December 31, 2022 | 0.8442 |
| September 30, 2022 | 0.888 |
| June 30, 2022 | 0.9291 |
| March 31, 2022 | 0.936 |
| December 31, 2021 | 1.008 |
| September 30, 2021 | 1.094 |
| June 30, 2021 | 1.091 |
| March 31, 2021 | 1.089 |
| December 31, 2020 | 1.170 |
| September 30, 2020 | 1.211 |
| June 30, 2020 | 1.321 |
| March 31, 2020 | 1.478 |
| December 31, 2019 | 1.471 |
| September 30, 2019 | 1.576 |
| June 30, 2019 | 1.615 |
| March 31, 2019 | 1.641 |
| December 31, 2018 | 1.494 |
| September 30, 2018 | 1.589 |
| June 30, 2018 | 1.716 |
| March 31, 2018 | 1.691 |
| December 31, 2017 | 1.687 |
| Date | Value |
|---|---|
| September 30, 2017 | 2.335 |
| June 30, 2017 | 2.499 |
| March 31, 2017 | 2.667 |
| December 31, 2016 | 1.770 |
| September 30, 2016 | 1.910 |
| June 30, 2016 | 2.139 |
| March 31, 2016 | 2.184 |
| December 31, 2015 | 2.007 |
| September 30, 2015 | 2.146 |
| June 30, 2015 | 2.286 |
| March 31, 2015 | 2.488 |
| December 31, 2014 | 2.690 |
| September 30, 2014 | 2.849 |
| June 30, 2014 | 1.655 |
| March 31, 2014 | 1.659 |
| December 31, 2013 | 1.893 |
| September 30, 2013 | 1.808 |
| June 30, 2013 | 1.905 |
| March 31, 2013 | 2.031 |
| December 31, 2012 | 2.187 |
| September 30, 2012 | 2.461 |
| June 30, 2012 | 2.621 |
| March 31, 2012 | 2.791 |
| December 31, 2011 | 1.070 |
| September 30, 2011 | 1.143 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7493
Minimum
Dec 2023
1.615
Maximum
Jun 2019
1.111
Average
1.089
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.340B |
| Total Liabilities (Quarterly) | 1.739B |
| Shareholders Equity (Quarterly) | 1.601B |
| Current Ratio | 3.09 |
| Net Debt Paydown Yield | 1.57% |